Regeneron CEO 23andMe Bid - Search News

News

23andMe, Regeneron and Anne Wojcicki

Regeneron Backs Off 23andMe, Losing Bid to Former CEO

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” according to a spokesperson for the pharma.

CNBC on MSN · 3d

Former 23andMe CEO Anne Wojcicki wins bid for control of her former company, topping Regeneron

Anne Wojcicki, former chief executive of 23andMe, won a bid to acquire the genetic testing company she founded in a second auction.

Seeking Alpha on MSN · 1d

Regeneron is said to have declined a higher bid for 23andMe after Wojcicki's offer

Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a non-profit led by the company’s co-founder and former CEO Anne Wojcicki proposed a better offer to acquire the bankrupt DNA testing company.

13don MSN

Fate of 23andMe genetic data still not settled amid bankruptcy fight

Me is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, ...

GovInfoSecurity2d

23andMe's Co-Founder to Buy Company; Makes Privacy Pledge

TTAM Research Institute - 23andMe's co-founder and former CEO Anne Wojcicki's new company - is the winner in a final round of ...

2don MSN

Anne Wojcicki's bid to buy back 23andMe may not end a legal fight over DNA customer data

Anne Wojcicki’s winning bid to reclaim control of 23andMe doesn’t necessarily end the fight over what happens to the DNA of ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results